€35.00
Tirzepatide
Tirzepatide is a dual agonist of the GIP and GLP-1 receptors developed for managing type 2 diabetes and reducing body weight in affected patients. Administered via a weekly subcutaneous injection using a pre-filled syringe, it works by decreasing appetite, increasing glucose-dependent insulin secretion, and improving glycemic control. Clinical results show significant reductions in HbA1c and weight loss greater than that observed with certain standard treatments.
⚠️Important note
Each product must be mixed with bacteriostatic water. A Free 3ml bottle is included with every purchase.
Description
Tirzepatide is a dual agonist of the GIP and GLP-1 receptors developed for managing type 2 diabetes and reducing body weight in affected patients. Administered via a weekly subcutaneous injection using a pre-filled syringe, it works by decreasing appetite, increasing glucose-dependent insulin secretion, and improving glycemic control. Clinical results show significant reductions in HbA1c a greater than that observed with certain standard treatments.
Key features:
- Mechanism: dual GIP/GLP-1 agonist
- Route: weekly subcutaneous injection
- Presentation: injectable formulations
- Expected effects: improvement of blood sugar levels, fat loss, reduction of
appetite
Customer benefits:
- Better glycemic control and reduction of HbA1c
- Clinical and sustainable weight loss under medical supervision
- Clinical and sustainable weight loss under medical supervision
Convenient weekly administration schedule
Reviews
There are no reviews yet.